Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Celldex Therapeutics, Inc. | SR. VP & CCO | Common Stock | 20.8K | $708K | $33.99 | Jun 3, 2024 | Direct |
Celldex Therapeutics, Inc. | SR. VP & CCO | Incentive Stock Option (right to buy) | 65K | Jun 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CLDX | Celldex Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 17, 2024 | SR. VP & CCO |
CLDX | Celldex Therapeutics, Inc. | Jun 3, 2024 | 8 | -$312K | 4 | Jun 5, 2024 | SR. VP & CCO |
CLDX | Celldex Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | SR. VP & CCO |
CLDX | Celldex Therapeutics, Inc. | Aug 15, 2022 | 3 | -$419K | 4 | Aug 17, 2022 | SR. VP & CCO |
CLDX | Celldex Therapeutics, Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 17, 2022 | SR. VP & CCO |
CLDX | Celldex Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Sr. VP & CCO |